RUNX3 negatively regulates CD36 expression in myeloid cell lines

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2107-2114

  Puig Kröger, Amaya ^a   Domínguez Soto, Angeles ^a   Martínez Muñoz, Laura ^b   Serrano Gómez, Diego ^a   Lopez Bravo, María ^e   Sierra Filardi, Elena ^a   Fernández Ruiz, Elena ^b   Ruiz Velasco, Natividad ^a   Ardavín, Carlos ^e   Groner, Yoram ^c   Tandon, Narendra ^d   Corbí, Angel L ^a   Vega, Miguel A ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; DIACYLGLYCEROL DERIVATIVE; LIPOPROTEIN; LONG CHAIN FATTY ACID; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CD36 GENE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INFECTION SENSITIVITY; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 33746901650     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2107     Document Type: Article

References (42)

1. Nozaki, S., H. Kashiwagi, S. Yamashita, T. Nakagawa, B. Kostner, Y. Tomiyama, A. Nakata, M. Ishigami, J. Miyagawa, K. Kameda-Takemura, et al. 1995. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96: 1859-1865.
2. El Khoury, J. B., K. J. Moore, T. K. Means, J. Leung, K. Terada, M. Toft, M. W. Freeman, and A. D. Luster. 2003. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197: 1657-1666.
3. Jimenez, B., O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein, and N. Bouck. 2000. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6: 41-48.
4. Ibrahimi, A., A. Bonen, W. D. Blinn, T. Hajri, X. Li, K. Zhong, R. Cameron, and N. A. Abumrad. 1999. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274: 26761-26766.
5. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188: 1359-1368.
6. 3). J. Immunol. 161: 6250-6257.
7. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
8. Doyen, V., M. Rubio, D. Braun, T. Nakajima, J. Abe, H. Saito, G. Delespesse, and M. Sarfati. 2003. Thrombospondin I is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198: 1277-1283.
9. Chen, X., K. Doffek, S. L. Sugg, and J. Shilyansky. 2004. Phosphatidylserine regulates the maturation of human dendritic cells. J. Immunol. 173: 2985-2994.
10. Urban, B. C., N. Willcox, and D. J. Roberts. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98: 8750-8755.
11. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
12. Armesilla, A. L., D. Calvo, and M. A. Vega. 1996. Structural and functional characterization of the human CD36 gene promoter: identification of a proximal PEBP2/CBF site. J. Biol. Chem. 271: 7781-7787.
13. Sato, O., C. Kuriki, Y. Fukui, and K. Motojima. 2002. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α and γ ligands. J. Biol. Chem. 277: 15703-15711.
14. Huh, H. Y., S. F. Pearce, L. M. Yesner, J. L. Schindler, and R. L. Silverstein. 1996. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87: 2020-2028.
15. Tontonoz, P., L. Nagy, J. G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
16. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
17. Han, J., D. P. Hajjar, J. M. Tauras, J. Feng, A. M. Gotto, Jr., and A. C. Nicholson. 2000. Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ. J. Biol. Chem. 275: 1241-1246.
18. Ho, Y. 2004. Oncogenic potential of the RUNX gene family: "overview". Oncogene 23: 4198-4208.
19. Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, et al. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124.
20. Levanon, D., D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, et al. 2002. The RUNX3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21: 3454-3463.
21. Brenner, O., D. Levanon, V. Negreanu, O. Golubkov, O. Fainaru, E. Woolf, and Y. Groner. 2004. Loss of RUNX3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA 101: 16016-16021.
22. Fainaru, O., E. Woolf, J. Lotem, M. Yarmus, O. Brenner, D. Goldenberg, V. Negreanu, Y. Bernstein, D. Levanon, S. Jung, and Y. Groner. 2004. RUNX3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. FMBO J. 23: 969-979.
23. Huang, Q., D. Liu, P. Majewski, L. C. Schulte, J. M. Korn, R. A. Young, E. S. Lander, and N. Hacohen. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875.
24. Nau, G. J., J. F. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99: 1503-1508.
25. Puig-Kroger, A., T. Sanchez-Elsner, N. Ruiz, E. J. Andreu, F. Prosper, U. B. Jensen, J. Gil, P. Erickson, H. Drabkin, Y. Groner, and A. L. Corbi. 2003. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 102: 3252-3261.
26. Le, X. F., Y. Groner, S. M. Kornblau, Y. Gu, W. N. Hittelman, D. Levanon, K. Mehta, R. B. Arlinghaus, and K. S. Chang. 1999. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway. J. Biol. Chem. 274: 21651-21658.
27. Tandon, N. N., R. H. Lipsky, W. H. Burgess, and G. A. Jamieson. 1989. Isolation and characterization of platelet glycoprotein IV (CD36). J. Biol. Chem. 264: 7570-7575.
28. Feng, J., J. Han, S. F. Pearce, R. L. Silverstein, A. M. Gotto, Jr., D. P. Hajjar, and A. C. Nicholson. 2000. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ. J. Lipid Res. 41: 688-696.
29. Yesner, L. M., H. Y. Huh, S. F. Pearce, and R. L. Silverstein. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025.
30. Granelli-Piperno, A., M. Pope, K. Inaba, and R. M. Steinman. 1995. Coexpression of NF-κB/Rel and Spl transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia. Proc. Natl. Acad. Sci. USA 92: 10944-10948.
31. Puig-Kroger, A., D. Serrano-Gomez, E. Caparros, A. Dominguez-Soto, M. Relloso, M. Colmenares, L. Martinez-Munoz, N. Longo, N. Sanchez-Sanchez, M. Rincon, et al. 2004. Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grahbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. J. Biol. Chem. 279: 25680-25688.
32. + murine dendritic cells. J. Immunol. 168: 6057-6065.
33. + splenic dendritic cells but is not required for cross-presentation in vivo. J. Immunol. 168: 6066-6070.
34. Durst, K. L., and S. W. Hiebert. 2004. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23: 4220-4224.
35. Telfer, J. C., E. E. Hedblom, M. K. Anderson, M. N. Laurent, and E. V. Rothenberg. 2004. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 172: 4359-4370.
36. Ito, Y., and K. Miyazono. 2003. RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr. Opin. Genet. Dev. 13: 43-47.
37. Miyazono, K., S. Maeda, and T. Imamura. 2004. Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins. Oncogene 23: 4232-4237.
38. Shi, M. J., and J. Stavnezer. 1998. CBF α3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J. Immunol. 161: 6751-6760.
39. Hanai, J., L. F. Chen, T. Kanno, N. Ohtani-Fujita, W. Y. Kim, W. H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M. J. Shi, et al. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274: 31577-31582.
40. Jin, Y. H., E. J. Jeon, Q. L. Li, Y. H. Lee, J. K. Choi, W. J. Kim, K. Y. Lee, and S. C. Bae. 2004. Transforming growth factor-β stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279: 29409-29417.
41. Bangsow, C., N. Rubins, G. Glusman, Y. Bernstein, V. Negreanu, D. Goldenberg, J. Lotem, E. Ben-Asher, D. Lancet, D. Levanon, and Y. Groner. 2001. The RUNX3 gene-sequence, structure and regulated expression. Gene 279: 221-232.
42. Wilson, N. S., D. El-Sukkari, and J. A. Villadangos. 2004. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103: 2187-2195.